Phosphotyrosine-binding domains in signal transduction

Nature Reviews Molecular Cell Biology

Volumn 3, Issue 3, 2002, Pages 177-186

  Yaffe, Michael B ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMINO ACID; GROWTH FACTOR RECEPTOR; PHOSPHOTYROSINE; PROTEIN; PROTEIN TYROSINE KINASE; LIGAND;

CELL FUNCTION; COMPLEX FORMATION; HUMAN; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; BINDING SITES; HUMANS; LIGANDS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PHOSPHOTYROSINE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 0036518996     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm759     Document Type: Review

References (148)

1. Kuriyan, J. & Cowburn, D. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26, 259-288 (1997). A thorough and detailed review of the structural basis for peptide binding by SH2, SH3 and PTB domains.
2. Mayer, B. J. & Gupta, R. Functions of SH2 and SH3 domains. Curr. Top. Microbiol. Immunol. 228, 1-22 (1998).
3. Pawson, T. & Scott, J. D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080 (1997). A classic summary of modular signalling domains. Much of the information has not been presented in later reviews.
4. gag-lps. Mol. Cell. Biol. 6, 4396-4408 (1986). The first description of the SH2 domain.
5. DeClue, J. E., Sadowski, I., Martin, G. S. & Pawson, T. A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc. Natl Acad. Sci. USA 84, 9064-9068 (1987).
6. Cross, F. R., Garber, E. A. & Hanafusa, H. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol. Cell. Biol. 5, 2789-2795 (1985).
7. Raymond, V. W. & Parsons, J. T. Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology 160, 400-410 (1987).
8. Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001).
9. Anderson, D. et al. Binding of SH2 domains of phospholipase Cγ1, GAP, and Src to activated growth factor receptors. Science 250, 979-982 (1990).
10. gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248, 1537-1539 (1990).
11. Matsuda, M., Mayer, B. J. & Hanafusa, H. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins. Mol. Cell. Biol. 11, 1607-1613 (1991).
12. Mayer, B. J., Jackson, P. K. & Baltimore, D. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl Acad. Sci. USA 88, 627-631 (1991).
13. Moran, M. F. et al. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl Acad. Sci. USA 87, 8622-8626 (1990).
14. Cantley, L. C. et al. Oncogenes and signal transduction. Cell 64, 281-302 (1991). A unified view of signal transduction involving protein-tyrosine-kinase and lipid-kinase signalling that was remarkably prescient and is still timely.
15. Margolis, B. et al. The tyrosine phosphorylated carboxy-terminus of the EGF receptor is a binding site for GAP and PLC-γ. EMBO J. 9, 4375-4380 (1990).
16. Escobedo, J. A., Kaplan, D. R., Kavanaugh, W. M., Turck, C. W. & Williams, L. T. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol. Cell. Biol. 11, 1125-1132 (1991).
17. Fantl, W. J. et al. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69, 413-423 (1992). This was one of the first studies that showed that distinct phosphotyrosine sites on receptor tyrosine kinases recruit different signalling molecules.
18. Kazlauskas, A., Kashishian, A., Cooper, J. A. & Valius, M. GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor β subunit. Mol. Cell. Biol. 12, 2534-2544 (1992).
19. Valius, M., Bazenet, C. & Kazlauskas, A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β-subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13, 133-143 (1993).
20. Kazlauskas, A., Feng, G. S., Pawson, T. & Valius, M. The 64-kDa protein that associates with the platelet-derived growth factor receptor β subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc. Natl Acad. Sci. USA 90, 6939-6943 (1993).
21. Ronnstrand, L. et al. Identification of two C-terminal autophosphorylation sites in the PDGF β-receptor: involvement in the interaction with phospholipase C-γ. EMBO J. 11, 3911-3919 (1992).
22. Yoakim, M, et al. Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase. J. Virol. 66, 5485-5491 (1992).
23. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993). The first description of the use of oriented peptide-library screening to deduce phosphotyrosine motifs that are recognized by different SH2 domains.
24. Songyang, Z. et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14, 2777-2785 (1994).
25. Waksman, G., Shoelson, S. E., Pant, N., Cowburn, D. & Kuriyan, J. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72, 779-790 (1993). A classic study of structural biology that shows how SH2 domains bind to phosphotyrosine-containing peptides.
26. Lee, C. H. et al. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure 2, 423-438 (1994).
27. Nolte, R. T., Eck, M. J., Schlessinger J., Shoelson, S. E. & Harrison, S. C. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nature Struct. Biol. 3, 364-374 (1996).
28. Tong, L. et al. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 Å and 1.8 Å resolution. J. Mol. Biol. 256, 601-610 (1996).
29. Poy, F. et al. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell 4, 555-561 (1999).
30. Yaffe, M. B. et al. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nature Biotechnol. 19, 348-353 (2001).
31. Pawson, T. Protein modules and signalling networks. Nature 373, 573-580 (1995).
32. Pawson, T. & Nash, P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027-1047 (2000). An excellent and up-to-date review of many modular domains and their roles in cell signalling and development.
33. Waksman, G. et al. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653 (1992).
34. lck. Nature 362, 87-91 (1993).
35. Bradshaw, J. M., Mitaxov, V. & Waksman, G. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. J. Mol. Biol. 293, 971-985 (1999).
36. Bradshaw, J. M. & Waksman, G. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics. Biochemistry 38, 5147-5154 (1999).
37. Kimber, M.S. et al. Structural basis for specificity switching of the Src SH2 domain. Mol. Cell 5, 1043-1049 (2000).
38. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998).
39. Morrione, A. et al. mGrb10 interacts with Nedd4. J. Biol. Chem. 274, 24094-24099 (1999).
40. Li, S. C. et al. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. Curr. Biol. 9, 1355-1362 (1999).
41. Marengere, L. E. et al. SH2 domain specificity and activity modified by a single residue. Nature 369, 502-505 (1994).
42. Valius, M. & Kazlauskas, A. Phospholipase C-γ1 and phosphatidylinositol-3-kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73, 321-334 (1993).
43. Montmayeur, J. P., Valius, M., Vandenheede, J. & Kazlauskas, A. The platelet-derived growth factor β receptor triggers multiple cytoplasmic signaling cascades that arrive at the nucleus as distinguishable inputs. J. Biol. Chem. 272, 32670-32678 (1997).
44. Tallquist, M. D. et al. Retention of PDGFR-β function in mice in the absence of phosphatidylinositol-3′-kinase and phospholipase Cγ signaling pathways. Genes Dev. 14, 3179-3190 (2000).
45. Lesa, G. M. & Sternberg, P. W. Positive and negative tissue-specific signaling by a nematode epidermal growth factor receptor. Mol. Biol. Cell 8, 779-793 (1997).
46. Soler, C., Beguinot, L. & Carpenter, G. Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J. Biol. Chem. 269, 12320-12324 (1994).
47. Li, N., Schlessinger, J. & Margolis, B. Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. Oncogene 9, 3457-3465 (1994).
48. Birchmeier, C. & Gherardi, E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404-410 (1998).
49. Maina, F. et al. Coupling Met to specific pathways results in distinct developmental outcomes. Mol. Cell 7, 1293-1306 (2001).
50. Lowenstein, E. J. et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70, 431-442 (1992). The first of several papers to describe Grb2 as a link between receptor tyrosine kinases and Raf (see also references 53-56).
51. Pelicci, G. et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104 (1992). This report was the first identification of SHC.
52. Margolis, B. et al. High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. Proc. Natl Acad. Sci. USA 89, 8894-8898 (1992).
53. Li, N. et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363, 85-88 (1993).
54. Olivier, J. P. et al. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos. Cell 73, 179-191 (1993).
55. Gale, N. W., Kaplan, S., Lowenstein, E. J., Schlessinger, J. & Bar-Sagi, D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363, 88-92 (1993).
56. Egan, S. E. et al. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363, 45-51 (1993).
57. Lechleider, R. J. et al. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J. Biol. Chem. 268, 21478-21481 (1993).
58. Klinghoffer, R. A. & Kazlauskas, A. Identification of a putative Syp substrate, the PDGF β receptor. J. Biol. Chem. 270, 22208-22217 (1995).
59. Cleghon, V. et al. Drosophila terminal structure development is regulated by the compensatory activities of positive and negative phosphotyrosine signaling sites on the Torso RTK. Genes Dev. 10, 566-577 (1996).
60. Cleghon, V. et al. Opposing actions of CSW and RasGAP modulate the strength of Torso RTK signaling in the Drosophila terminal pathway. Mol. Cell 2, 719-727 (1998).
61. Galisteo, M. L., Dikic, I., Batzer, A. G., Langdon, W. Y. & Schlessinger, J. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem. 270, 20242-20245 (1995).
62. Meng, W., Sawasdikosol, S., Burakoff, S. J. & Eck, M. J. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398, 84-90 (1999).
63. Joazeiro, C. A. et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312 (1999). Together with references 64-67, this paper elucidates the recognition of Cbl as a ubiquitin ligase.
64. Levkowitz, G. et al. c-Cbl/Sli-l regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12, 3663-3674 (1998).
65. Lill, N. L. et al. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 275, 367-377 (2000).
66. Miyake, S., Lupher, M. L. Jr, Druker, B. & Band, H. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor. Proc. Natl Acad. Sci. USA 95, 7927-7932 (1998).
67. Waterman, H., Levkowitz, G., Alroy, I. & Yarden, Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J. Biol. Chem. 274, 22151-22154 (1999).
68. Xu, W., Harrison, S. C. & Eck, M. J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602 (1997). Together with references 69-71, these papers defined the structure of Src-family tyrosine kinases and determined their mechanism of activation.
69. Sicheri, F., Moarefi, I. & Kuriyan, J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609 (1997).
70. Xu, W., Doshi, A., Lei, M., Eck, M. J. & Harrison, S. C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3, 629-638 (1999).
71. Young, M. A., Gonfloni, S., Superti-Furga, G., Roux, B. & Kudyan, J. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105, 115-126 (2001).
72. Liu, X. et al. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Oncogene 8, 1119-1126 (1993).
73. Moarefi, I. et al. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385, 650-653 (1997).
74. Mayer, B. J., Hirai, H. & Sakai, R. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5, 296-305 (1995). Together with references 75 and 76, these papers show that the SH2 domains of Src-family kinases function to enhance processive phosphorylation.
75. Pellicena, P., Stowell, K. R. & Miller, W. T. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites. J. Biol. Chem. 273, 15325-15328 (1998).
76. Scott, M. P. & Miller, W. T. A peptide model system for processive phosphorylation by Src family kinases. Biochemistry 39, 14531-14537 (2000).
77. Eck, M. J., Pluskey, S., Trub, T., Harrison, S. C. & Shoelson, S. E. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 379, 277-280 (1996).
78. Ottinger, E. A., Botfield, M. C. & Shoelson, S. E. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J. Biol. Chem. 273, 729-735 (1998).
79. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J. & Shoelson, S. E. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450 (1998).
80. Futterer, K., Wong, J., Grucza, R. A., Chan, A. C. & Waksman, G. Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J. Mol. Biol. 281, 523-537 (1998).
81. Blaikie, P. et al. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 269, 32031-32034 (1994). The first recognition of the PTB domain as an alternative phosphotyrosine-binding module.
82. Kavanaugh, W. M. & Williams, L. T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266, 1862-1865 (1994).
83. Gustafson, T. A., He, W., Craparo, A., Schaub, C. D. & O'Neill, T. J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15, 2500-2508 (1995).
84. Zhou, M. M. & Fesik, S. W. Structure and function of the phosphotyrosine binding (PTB) domain. Prog. Biophys. Mol. Biol. 64, 221-235 (1995).
85. Shoelson, S. E. SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr. Opin. Chem. Biol. 1, 227-234 (1997).
86. Zhou, Y. & Abagyan, R. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains. Fold. Des. 3, 513-522 (1998).
87. Forman-Kay, J. D. & Pawson, T. Diversity in protein recognition by PTB domains. Curr. Opin. Struct. Biol. 9, 690-695 (1999).
88. Margolis, B., Borg, J. P., Straight, S. & Meyer, D. The function of PTB domain proteins. Kidney Int. 56, 1230-1237 (1999).
89. Trub, T. et al. Specificity of the PTB domain of Shc for β turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J. Biol. Chem. 270, 18205-18208 (1995).
90. Van der Geer, P. et al. A conserved amino-terminal SHC domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr. Biol. 5, 404-412 (1995).
91. Van der Geer, P. et al. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc. Natl Acad. Sci. USA 93, 963-968 (1996).
92. Wolf, G. et al. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem. 270, 27407-27410 (1995).
93. Zhou, S., Margolis, B., Chaudhuri, M., Shoelson, S. E. & Cantley, L. C. The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J. Biol. Chem. 270, 14863-14866 (1995).
94. Li, S. C. et al. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein. J. Biol. Chem. 271, 31855-31862 (1996).
95. Laminet, A. A., Apell, G., Conroy, L. & Kavanaugh, W. M. Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors. J. Biol. Chem. 271, 264-269 (1996).
96. Borg, J. P., Ooi, J., Levy, E. & Margolis, B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 6229-6241 (1996).
97. Zhang, Z. et al. Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J. 16, 6141-6150 (1997).
98. Dho, S. E. et al. The mammalian numb phosphotyrosine-binding domain. Characterization of binding specificity and identification of a novel PDZ domain-containing numb binding protein, LNX. J. Biol. Chem. 273, 9179-9187 (1998).
99. Chien, C. T., Wang, S., Rothenberg, M., Jan, L. Y. & Jan, Y. N. Numb-associated kinase interacts with the phosphotyrosine binding domain of Numb and antagonizes the function of Numb in vivo. Mol. Cell. Biol. 18, 598-607 (1998).
100. Li, S. C. et al. Structure of a Numb PTB domain-peptide complex suggests a basis for diverse binding specificity. Nature Struct. Biol. 5, 1075-1083 (1998).
101. Meyer, D., Liu, A. & Margolis, B. Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J. Biol. Chem. 274, 35113-35118 (1999).
102. Peng, X., Greene, L. A., Kaplan, D. R. & Stephens, R. M. Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis. Neuron 15, 395-406 (1995).
103. Meakin, S. O., MacDonald, J. I., Gryz, E. A., Kubu, C. J. & Verdi, J. M. The signaling adapter FRS-2 competes with Shc for binding to the nerve growth factor receptor TrkA. A model for discriminating proliferation and differentiation. J. Biol. Chem. 274, 9861-9870 (1999).
104. Xu, H., Lee, K. W. & Goldfarb, M. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins. J. Biol. Chem. 273, 17987-17990 (1998).
105. Ong, S. H. et al. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 20, 979-989 (2000).
106. Zhou, M. M. et al. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378, 584-592 (1995). This study described the first PTB-domain structure that was solved by NMR.
107. Eck, M. J., Dhe-Paganon, S., Trub, T., Nolte, R. T. & Shoelson, S. E. Structure of the IRS-1 PTB domain bound to the juxtamembrene region of the insulin receptor. Cell 85, 695-705 (1996). The first X-ray structure of a PTB domain, which showed how the divergent IRS-1 and SHC PTB domains have the same basic fold but use different residues to bind to phosphotyrosine-containing ligands.
108. Zhou, M. M. et al. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nature Struct. Biol. 3, 388-393 (1996).
109. Zwahlen, C., Li, S. C., Kay, L. E., Pawson, T. & Forman-Kay, J. D. Multiple modes of peptide recognition by the PTB domain of the cell fate determinant Numb. EMBO J. 19, 1505-1515 (2000).
110. Dhalluin, C. et al. Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. Mol. Cell 6, 921-929 (2000).
111. Prehoda, K. E., Lee, D. J. & Lim, W. A. Structure of the enabled/ VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly. Cell 97, 471-480 (1999).
112. Fedorov, A. A., Fedorov, E., Gertler, F. & Almo, S. C. Structure of EVH1, a novel proline-rich ligand-binding module involved in cytoskeletal dynamics and neural function. Nature Struct. Biol. 6, 661-665 (1999).
113. Lemmon, M. A. & Ferguson, K. M. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350, 1-18 (2000).
114. Ravichandran, K. S. et al. Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo. Mol. Cell. Biol. 17, 5540-5549 (1997).
115. Howell, B. W., Lanier, L. M., Frank, R., Gertler, F. B. & Cooper, J. A. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol. 19, 5179-5188 (1999).
116. Farooq, A., Plotnikova, O., Zeng, L. & Zhou, M. M. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner. J. Biol. Chem. 274, 6114-6121 (1999).
117. Ravichandran, K. S. Signaling via Shc family adapter proteins. Oncogene 20, 6322-6330 (2001).
118. Yamanashi, Y. & Baltimore, D. Identification of the Abl- and RasGAP-associated 62 kDa protein as a docking protein. Dok. Cell 88, 205-211 (1997). Together with reference 119, this study described the first identification of p62dok as a membrane-associated RasGAP-binding molecule that is targeted by activated tyrosine kinases.
119. Carpino, N. et al. p62(Dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88, 197-204 (1997).
120. Jones, N. & Dumont, D. J. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 17, 1097-1108 (1998).
121. Jones, N. & Dumont, D. J. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation. Curr. Biol. 9, 1057-1060 (1999).
122. Dankort, D., Jeybala, N., Jones, N., Dumont, D. J. & Muller, W. J. Multiple ErbB-2/Neu phosphorylation sites mediate transformation through distinct effector proteins. J. Biol. Chem. 276, 38921-38928 (2001).
123. Wick, M. J., Dong, L. Q., Hu, D., Langlais, P. & Liu, P. Insulin receptor-mediated p62(superdok) tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GAP and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt. J. Biol. Chem. 276, 42843-42850 (2001).
124. Yamanashi, Y. et al. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev. 14, 11-16 (2000).
125. Nemorin, J. G. & Duplay, P. Evidence that Lick-mediated phosphorylation of p56dok and p62dok may play a role in CD2 signaling. J. Biol. Chem. 275, 14590-14597 (2000).
126. Holland, S. J. et al. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. EMBO J. 16, 3877-3888 (1997).
127. Trommsdorff, M., Borg, J. P., Margolis, B. & Herz, J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560 (1998).
128. Trommsdorff, M. et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701 (1999).
129. Sweet, H. O., Bronson, R. T., Johnson, K. R., Cook, S. A. & Davisson, M. T. Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration. Mamm. Genome 7, 798-802 (1996).
130. Sheldon, M. et al. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389, 730-733 (1997).
131. Ware, M. L. et al. Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron 19, 239-249 (1997).
132. Howell, B. W., Hawkes, R., Soriano, P. & Cooper, J. A. Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733-737 (1997).
133. Rice, D. S. et al. Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain. Development 125, 3719-3729 (1998).
134. Garcia, C. K. et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 1394-1398 (2001). This study showed that a form of autosomal recessive hypercholesterolaemia is caused by mutations in the ARH protein, which contains a PTB domain that might bind to the LDL receptor.
135. Guo, M., Jan, L. Y. & Jan, Y. N. Control of daughter cell fates during asymmetric division: interaction of Numb and Notch. Neuron 17, 27-41 (1996).
136. Yaich, L. et al. Functional analysis of the Numb phosphotyrosine-binding domain using site-directed mutagenesis. J. Biol. Chem. 273, 10381-10388 (1998).
137. Rahuel, J. et al. Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nature Struct. Biol. 3, 586-589 (1996).
138. Ogura, K. et al. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. J. Mol. Biol. 289, 439-445 (1999).
139. Saffran, D. C. et al. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N. Engl. J. Med. 330, 1488-1491 (1994).
140. Coffey, A. J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet. 20, 129-135 (1998).
141. Nichols, K. E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 95, 13765-13770 (1998).
142. Tartaglia, M. et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genet. 29, 465-468 (2001). An elegant example of how mutations in the SHP-2 amino-SH2 domain are associated with a human disease.
143. Vidal, M., Gigoux, V. & Garbay, C. SH2 and SH3 domains as targets for anti-proliferative agents. Crit. Rev. Oncol. Hematol. 40, 175-186 (2001).
144. Shakespeare, W. et al. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. Proc. Natl Acad. Sci. USA 97, 9373-9378 (2000).
145. Yaffe, M. B. & Cantley, L. C. Mapping specificity determinants for protein-protein association using protein fusions and random peptide libraries. Methods Enzymol. 328, 157-170 (2000).
146. Tong, A. H. et al. A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science 295, 321-324 (2002).
147. Brannetti, B., Via, A., Cestra, G., Cesareni, G. & Helmer-Citterich, M. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family. J. Mol. Biol. 298, 313-328 (2000).
148. Schultz, J., Milpetz, F., Bork, P. & Ponting, C. P. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl Acad. Sci. USA 95, 5857-5864 (1998). This study described a classic bioinformatics tool for the study of modular protein domains.